Pulmonary Arterial Hypertension (PAH) Panel
Use
This test is intended for individuals with relevant features who have a clinical or suspected diagnosis of pulmonary arterial hypertension (PAH) in the absence of known predisposing conditions. It is also for individuals with a family history of PAH, especially those with multiple affected relatives, to help identify potential genetic causes and guide clinical management.
Special Instructions
For ordering this test, sign in for standard institutional pricing or fax the order using the downloadable test requisition form if not ordering online through myPrevent. The platform options include Exome and Genome, with different specimen requirements for each.
Limitations
This test is performed on 11 genes related to pulmonary arterial hypertension. The accuracy and detection capabilities are subject to the limitations of the NGS and CNV methods used on either the Exome or Genome platform, and may not detect all genetic variants associated with PAH.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided